Regulatory challenges of personalized medicine in the real world: are the right patients being treated with CD19-targeting CAR T-cells?
Saved in:
| Title: | Regulatory challenges of personalized medicine in the real world: are the right patients being treated with CD19-targeting CAR T-cells? |
|---|---|
| Authors: | Sebe A; Paul-Ehrlich-Institut, Langen, Germany. attila.sebe@pei.de., Hernani R; Hematology Department, Hospital Clínico Universitario INCLIVA Biomedical Research Institute, Valencia, Spain., Müller-Berghaus J; Paul-Ehrlich-Institut, Langen, Germany. |
| Source: | EMBO molecular medicine [EMBO Mol Med] 2026 Jun; Vol. 18 (6), pp. 2007-2011. Date of Electronic Publication: 2026 Apr 27. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
